SYNCOMF

Syncom Formulations (India) Limited

Pharmaceuticals · ₹1,317 Cr market cap

A global generic pharmaceutical company established in 1995, Syncom Formulations manufactures and markets a comprehensive range of healthcare products across multiple therapeutic areas. Operating in more than 15 countries worldwide with registrations for over 400 pharmaceutical products, the company serves both domestic and international markets. Its distinctive strength lies in its diversified geographic footprint and expansive product portfolio catering to varied patient healthcare needs globally.

0
Tracked investors holding
0
Tracked moves
14
Share price

Track smart money in Syncom Formulations (India) Limited

Get alerted when a top investor buys or sells.

Get started
Syncom Formulations (India) Limited — investor holdings & smart-money activity · WhaleWatch